PMID: 3312851Nov 1, 1987

Symposium on antimicrobial agents. Metronidazole

Mayo Clinic Proceedings
J E Rosenblatt, R S Edson

Abstract

Metronidazole, a nitroimidazole derivative, is a unique antimicrobial agent that is active against both bacterial and parasitic organisms, although only the anaerobic members of these groups are susceptible. It has been used for the treatment of trichomoniasis for almost 30 years and is also effective in amebiasis and giardiasis. More recently, metronidazole has emerged as a principal agent for the treatment of anaerobic infections. It is highly effective against all species of anaerobes except certain non-spore-forming gram-positive bacilli and cocci and is the only agent rapidly bactericidal against the Bacteroides fragilis group. The hydroxy metabolite is 65% as effective as metronidazole and may play a major therapeutic role. Clinical studies have substantiated its efficacy for prophylaxis during elective colorectal surgical procedures and the treatment of deep abdominal sepsis (usually in combination with another agent such as an aminoglycoside). Metronidazole is the treatment of choice for bacterial vaginosis and seems to be as effective as vancomycin for treatment of Clostridium difficile-related diarrhea and colitis. Good blood levels are produced after both oral and intravenous administration, and side effects are infr...Continue Reading

References

Sep 1, 1978·The Journal of Antimicrobial Chemotherapy·S J Eykyn, I Phillips
Oct 1, 1975·Antimicrobial Agents and Chemotherapy·E D Ralph, W M Kirby
Sep 6, 1979·The New England Journal of Medicine·C M BeardM B Dockerty
Jan 1, 1978·Biochemical Pharmacology·R C KnightD I Edwards
Apr 1, 1977·Scottish Medical Journal·A T Willis
Jul 1, 1977·The Journal of Antimicrobial Chemotherapy·H GiamarellouG K Daikos
Oct 1, 1976·Antimicrobial Agents and Chemotherapy·V L Sutter, S M Finegold
Jul 1, 1972·The Journal of Infectious Diseases·L J Nastro, S M Finegold
Sep 1, 1967·The British Journal of Venereal Diseases·A H Davies
Feb 2, 1984·The New England Journal of Medicine·H Most
May 1, 1981·Reviews of Infectious Diseases·J G BartlettA B Onderdonk

Citations

Nov 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B OrenR Raz
Jan 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·R M van der WeidenA M Polderman
Jan 23, 2003·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M M López NigroM A Carballo
Jan 13, 2000·Alimentary Pharmacology & Therapeutics·E J van der WoudenJ H Kleibeuker
Nov 1, 1995·British Journal of Clinical Pharmacology·M N MuscaráG De Nucci
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·S L PendlandL H Danziger
Jan 1, 1993·Journal of Periodontology·G Greenstein
Jan 1, 1989·Scandinavian Journal of Gastroenterology. Supplement·E Quiros-Buelna
Jan 5, 2002·Scandinavian Journal of Gastroenterology. Supplement·E J van der WoudenJ H Kleibeuker
Sep 1, 1992·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·T T Rice

Related Concepts

Bacteroides Infections
Necrobacillosis
Gram-Negative Anaerobic Bacteria
Bayer 5360
Parasitic Diseases

Related Feeds

Bacterial Vaginosis

Bacterial vaginosis can increase the risk of sexually transmitted infections and in rare cases lead to pelvic inflammatory diseases. Discover the latest research on Bacterial Vaginosis here.

Amoebiasis

Amoebiasis, infection by the protozoan parasite Entamoeba histolytica, remains a global health problem, despite the availability of effective treatment. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.